Click for best price
Orphan Drugs Market Size, Share 2022
This report contains market size and forecasts of Orphan Drugs in global, including the following market information:
Global Orphan Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Orphan Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Orphan Drugs companies in 2021 (%)
The global Orphan Drugs market was valued at 126280 million in 2021 and is projected to reach US$ 235070 million by 2028, at a CAGR of 9.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oncology Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Orphan Drugs include Novartis, Bristol-Myers Squibb Company, Celgene, F. Hoffmann-La Roche, Pfizer, Sanofi, Alexion Pharmaceuticals, Eli Lilly and Company and Novo Nordisk, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Orphan Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Orphan Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Orphan Drugs Market Segment Percentages, by Type, 2021 (%)
Oncology
Gastrointestinal
Pulmonary
Neurology
Hematology
Cardio-vascular
Metabolic Disorders
Endocrinology
Infectious Diseases
Others
Global Orphan Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Orphan Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail pharmacies
Others
Global Orphan Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Orphan Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Orphan Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Orphan Drugs revenues share in global market, 2021 (%)
Key companies Orphan Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Orphan Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Bristol-Myers Squibb Company
Celgene
F. Hoffmann-La Roche
Pfizer
Sanofi
Alexion Pharmaceuticals
Eli Lilly and Company
Novo Nordisk
AstraZeneca
Eisai
Daiichi Sankyo Company
Bayer
GlaxoSmithKline
Merck & Co
Johnson & Johnson
Biogen
Takeda
Amgen
| Report Attributes |
Report Details |
| Report Title |
Orphan Drugs Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
115 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Orphan Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Orphan Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Orphan Drugs Overall Market Size
2.1 Global Orphan Drugs Market Size: 2021 VS 2028
2.2 Global Orphan Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Orphan Drugs Sales: 2017-2028
3 Company Landscape
3.1 Top Orphan Drugs Players in Global Market
3.2 Top Global Orphan Drugs Companies Ranked by Revenue
3.3 Global Orphan Drugs Revenue by Companies
3.4 Global Orphan Drugs Sales by Companies
3.5 Global Orphan Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Orphan Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Orphan Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Orphan Drugs Players in Global Market
3.8.1 List of Global Tier 1 Orphan Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Orphan Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Orphan Drugs Market Size Markets, 2021 & 2028
4.1.2 Oncology
4.1.3 Gastrointestinal
4.1.4 Pulmonary
4.1.5 Neurology
4.1.6 Hematology
4.1.7 Cardio-vascular
4.1.8 Metabolic Disorders
4.1.9 Endocrinology
4.1.10 Infectious Diseases
4.1.11 Others
4.2 By Type - Global Orphan Drugs Revenue & Forecasts
4.2.1 By Type - Global Orphan Drugs Revenue, 2017-2022
4.2.2 By Type - Global Orphan Drugs Revenue, 2023-2028
4.2.3 By Type - Global Orphan Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Orphan Drugs Sales & Forecasts
4.3.1 By Type - Global Orphan Drugs Sales, 2017-2022
4.3.2 By Type - Global Orphan Drugs Sales, 2023-2028
4.3.3 By Type - Global Orphan Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Orphan Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Orphan Drugs Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail pharmacies
5.1.4 Others
5.2 By Application - Global Orphan Drugs Revenue & Forecasts
5.2.1 By Application - Global Orphan Drugs Revenue, 2017-2022
5.2.2 By Application - Global Orphan Drugs Revenue, 2023-2028
5.2.3 By Application - Global Orphan Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Orphan Drugs Sales & Forecasts
5.3.1 By Application - Global Orphan Drugs Sales, 2017-2022
5.3.2 By Application - Global Orphan Drugs Sales, 2023-2028
5.3.3 By Application - Global Orphan Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Orphan Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Orphan Drugs Market Size, 2021 & 2028
6.2 By Region - Global Orphan Drugs Revenue & Forecasts
6.2.1 By Region - Global Orphan Drugs Revenue, 2017-2022
6.2.2 By Region - Global Orphan Drugs Revenue, 2023-2028
6.2.3 By Region - Global Orphan Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Orphan Drugs Sales & Forecasts
6.3.1 By Region - Global Orphan Drugs Sales, 2017-2022
6.3.2 By Region - Global Orphan Drugs Sales, 2023-2028
6.3.3 By Region - Global Orphan Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Orphan Drugs Revenue, 2017-2028
6.4.2 By Country - North America Orphan Drugs Sales, 2017-2028
6.4.3 US Orphan Drugs Market Size, 2017-2028
6.4.4 Canada Orphan Drugs Market Size, 2017-2028
6.4.5 Mexico Orphan Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Orphan Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Orphan Drugs Sales, 2017-2028
6.5.3 Germany Orphan Drugs Market Size, 2017-2028
6.5.4 France Orphan Drugs Market Size, 2017-2028
6.5.5 U.K. Orphan Drugs Market Size, 2017-2028
6.5.6 Italy Orphan Drugs Market Size, 2017-2028
6.5.7 Russia Orphan Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Orphan Drugs Market Size, 2017-2028
6.5.9 Benelux Orphan Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Orphan Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Orphan Drugs Sales, 2017-2028
6.6.3 China Orphan Drugs Market Size, 2017-2028
6.6.4 Japan Orphan Drugs Market Size, 2017-2028
6.6.5 South Korea Orphan Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Orphan Drugs Market Size, 2017-2028
6.6.7 India Orphan Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Orphan Drugs Revenue, 2017-2028
6.7.2 By Country - South America Orphan Drugs Sales, 2017-2028
6.7.3 Brazil Orphan Drugs Market Size, 2017-2028
6.7.4 Argentina Orphan Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Orphan Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Orphan Drugs Sales, 2017-2028
6.8.3 Turkey Orphan Drugs Market Size, 2017-2028
6.8.4 Israel Orphan Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Orphan Drugs Market Size, 2017-2028
6.8.6 UAE Orphan Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Corporate Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Orphan Drugs Major Product Offerings
7.1.4 Novartis Orphan Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Novartis Key News
7.2 Bristol-Myers Squibb Company
7.2.1 Bristol-Myers Squibb Company Corporate Summary
7.2.2 Bristol-Myers Squibb Company Business Overview
7.2.3 Bristol-Myers Squibb Company Orphan Drugs Major Product Offerings
7.2.4 Bristol-Myers Squibb Company Orphan Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Bristol-Myers Squibb Company Key News
7.3 Celgene
7.3.1 Celgene Corporate Summary
7.3.2 Celgene Business Overview
7.3.3 Celgene Orphan Drugs Major Product Offerings
7.3.4 Celgene Orphan Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Celgene Key News
7.4 F. Hoffmann-La Roche
7.4.1 F. Hoffmann-La Roche Corporate Summary
7.4.2 F. Hoffmann-La Roche Business Overview
7.4.3 F. Hoffmann-La Roche Orphan Drugs Major Product Offerings
7.4.4 F. Hoffmann-La Roche Orphan Drugs Sales and Revenue in Global (2017-2022)
7.4.5 F. Hoffmann-La Roche Key News
7.5 Pfizer
7.5.1 Pfizer Corporate Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Orphan Drugs Major Product Offerings
7.5.4 Pfizer Orphan Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Pfizer Key News
7.6 Sanofi
7.6.1 Sanofi Corporate Summary
7.6.2 Sanofi Business Overview
7.6.3 Sanofi Orphan Drugs Major Product Offerings
7.6.4 Sanofi Orphan Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Sanofi Key News
7.7 Alexion Pharmaceuticals
7.7.1 Alexion Pharmaceuticals Corporate Summary
7.7.2 Alexion Pharmaceuticals Business Overview
7.7.3 Alexion Pharmaceuticals Orphan Drugs Major Product Offerings
7.7.4 Alexion Pharmaceuticals Orphan Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Alexion Pharmaceuticals Key News
7.8 Eli Lilly and Company
7.8.1 Eli Lilly and Company Corporate Summary
7.8.2 Eli Lilly and Company Business Overview
7.8.3 Eli Lilly and Company Orphan Drugs Major Product Offerings
7.8.4 Eli Lilly and Company Orphan Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Eli Lilly and Company Key News
7.9 Novo Nordisk
7.9.1 Novo Nordisk Corporate Summary
7.9.2 Novo Nordisk Business Overview
7.9.3 Novo Nordisk Orphan Drugs Major Product Offerings
7.9.4 Novo Nordisk Orphan Drugs Sales and Revenue in Global (2017-2022)
7.9.5 Novo Nordisk Key News
7.10 AstraZeneca
7.10.1 AstraZeneca Corporate Summary
7.10.2 AstraZeneca Business Overview
7.10.3 AstraZeneca Orphan Drugs Major Product Offerings
7.10.4 AstraZeneca Orphan Drugs Sales and Revenue in Global (2017-2022)
7.10.5 AstraZeneca Key News
7.11 Eisai
7.11.1 Eisai Corporate Summary
7.11.2 Eisai Orphan Drugs Business Overview
7.11.3 Eisai Orphan Drugs Major Product Offerings
7.11.4 Eisai Orphan Drugs Sales and Revenue in Global (2017-2022)
7.11.5 Eisai Key News
7.12 Daiichi Sankyo Company
7.12.1 Daiichi Sankyo Company Corporate Summary
7.12.2 Daiichi Sankyo Company Orphan Drugs Business Overview
7.12.3 Daiichi Sankyo Company Orphan Drugs Major Product Offerings
7.12.4 Daiichi Sankyo Company Orphan Drugs Sales and Revenue in Global (2017-2022)
7.12.5 Daiichi Sankyo Company Key News
7.13 Bayer
7.13.1 Bayer Corporate Summary
7.13.2 Bayer Orphan Drugs Business Overview
7.13.3 Bayer Orphan Drugs Major Product Offerings
7.13.4 Bayer Orphan Drugs Sales and Revenue in Global (2017-2022)
7.13.5 Bayer Key News
7.14 GlaxoSmithKline
7.14.1 GlaxoSmithKline Corporate Summary
7.14.2 GlaxoSmithKline Business Overview
7.14.3 GlaxoSmithKline Orphan Drugs Major Product Offerings
7.14.4 GlaxoSmithKline Orphan Drugs Sales and Revenue in Global (2017-2022)
7.14.5 GlaxoSmithKline Key News
7.15 Merck & Co
7.15.1 Merck & Co Corporate Summary
7.15.2 Merck & Co Business Overview
7.15.3 Merck & Co Orphan Drugs Major Product Offerings
7.15.4 Merck & Co Orphan Drugs Sales and Revenue in Global (2017-2022)
7.15.5 Merck & Co Key News
7.16 Johnson & Johnson
7.16.1 Johnson & Johnson Corporate Summary
7.16.2 Johnson & Johnson Business Overview
7.16.3 Johnson & Johnson Orphan Drugs Major Product Offerings
7.16.4 Johnson & Johnson Orphan Drugs Sales and Revenue in Global (2017-2022)
7.16.5 Johnson & Johnson Key News
7.17 Biogen
7.17.1 Biogen Corporate Summary
7.17.2 Biogen Business Overview
7.17.3 Biogen Orphan Drugs Major Product Offerings
7.17.4 Biogen Orphan Drugs Sales and Revenue in Global (2017-2022)
7.17.5 Biogen Key News
7.18 Takeda
7.18.1 Takeda Corporate Summary
7.18.2 Takeda Business Overview
7.18.3 Takeda Orphan Drugs Major Product Offerings
7.18.4 Takeda Orphan Drugs Sales and Revenue in Global (2017-2022)
7.18.5 Takeda Key News
7.19 Amgen
7.19.1 Amgen Corporate Summary
7.19.2 Amgen Business Overview
7.19.3 Amgen Orphan Drugs Major Product Offerings
7.19.4 Amgen Orphan Drugs Sales and Revenue in Global (2017-2022)
7.19.5 Amgen Key News
8 Global Orphan Drugs Production Capacity, Analysis
8.1 Global Orphan Drugs Production Capacity, 2017-2028
8.2 Orphan Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Orphan Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Orphan Drugs Supply Chain Analysis
10.1 Orphan Drugs Industry Value Chain
10.2 Orphan Drugs Upstream Market
10.3 Orphan Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Orphan Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Orphan Drugs in Global Market
Table 2. Top Orphan Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Orphan Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Orphan Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Orphan Drugs Sales by Companies, (K Units), 2017-2022
Table 6. Global Orphan Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Orphan Drugs Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Orphan Drugs Product Type
Table 9. List of Global Tier 1 Orphan Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Orphan Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Orphan Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Orphan Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Orphan Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Orphan Drugs Sales (K Units), 2017-2022
Table 15. By Type - Global Orphan Drugs Sales (K Units), 2023-2028
Table 16. By Application ? Global Orphan Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Orphan Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Orphan Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Orphan Drugs Sales (K Units), 2017-2022
Table 20. By Application - Global Orphan Drugs Sales (K Units), 2023-2028
Table 21. By Region ? Global Orphan Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Orphan Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Orphan Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Orphan Drugs Sales (K Units), 2017-2022
Table 25. By Region - Global Orphan Drugs Sales (K Units), 2023-2028
Table 26. By Country - North America Orphan Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Orphan Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Orphan Drugs Sales, (K Units), 2017-2022
Table 29. By Country - North America Orphan Drugs Sales, (K Units), 2023-2028
Table 30. By Country - Europe Orphan Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Orphan Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Orphan Drugs Sales, (K Units), 2017-2022
Table 33. By Country - Europe Orphan Drugs Sales, (K Units), 2023-2028
Table 34. By Region - Asia Orphan Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Orphan Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Orphan Drugs Sales, (K Units), 2017-2022
Table 37. By Region - Asia Orphan Drugs Sales, (K Units), 2023-2028
Table 38. By Country - South America Orphan Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Orphan Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Orphan Drugs Sales, (K Units), 2017-2022
Table 41. By Country - South America Orphan Drugs Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Orphan Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Orphan Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Orphan Drugs Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Orphan Drugs Sales, (K Units), 2023-2028
Table 46. Novartis Corporate Summary
Table 47. Novartis Orphan Drugs Product Offerings
Table 48. Novartis Orphan Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Bristol-Myers Squibb Company Corporate Summary
Table 50. Bristol-Myers Squibb Company Orphan Drugs Product Offerings
Table 51. Bristol-Myers Squibb Company Orphan Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Celgene Corporate Summary
Table 53. Celgene Orphan Drugs Product Offerings
Table 54. Celgene Orphan Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. F. Hoffmann-La Roche Corporate Summary
Table 56. F. Hoffmann-La Roche Orphan Drugs Product Offerings
Table 57. F. Hoffmann-La Roche Orphan Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Pfizer Corporate Summary
Table 59. Pfizer Orphan Drugs Product Offerings
Table 60. Pfizer Orphan Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Sanofi Corporate Summary
Table 62. Sanofi Orphan Drugs Product Offerings
Table 63. Sanofi Orphan Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Alexion Pharmaceuticals Corporate Summary
Table 65. Alexion Pharmaceuticals Orphan Drugs Product Offerings
Table 66. Alexion Pharmaceuticals Orphan Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Eli Lilly and Company Corporate Summary
Table 68. Eli Lilly and Company Orphan Drugs Product Offerings
Table 69. Eli Lilly and Company Orphan Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Novo Nordisk Corporate Summary
Table 71. Novo Nordisk Orphan Drugs Product Offerings
Table 72. Novo Nordisk Orphan Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. AstraZeneca Corporate Summary
Table 74. AstraZeneca Orphan Drugs Product Offerings
Table 75. AstraZeneca Orphan Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Eisai Corporate Summary
Table 77. Eisai Orphan Drugs Product Offerings
Table 78. Eisai Orphan Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Daiichi Sankyo Company Corporate Summary
Table 80. Daiichi Sankyo Company Orphan Drugs Product Offerings
Table 81. Daiichi Sankyo Company Orphan Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. Bayer Corporate Summary
Table 83. Bayer Orphan Drugs Product Offerings
Table 84. Bayer Orphan Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 85. GlaxoSmithKline Corporate Summary
Table 86. GlaxoSmithKline Orphan Drugs Product Offerings
Table 87. GlaxoSmithKline Orphan Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 88. Merck & Co Corporate Summary
Table 89. Merck & Co Orphan Drugs Product Offerings
Table 90. Merck & Co Orphan Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 91. Johnson & Johnson Corporate Summary
Table 92. Johnson & Johnson Orphan Drugs Product Offerings
Table 93. Johnson & Johnson Orphan Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 94. Biogen Corporate Summary
Table 95. Biogen Orphan Drugs Product Offerings
Table 96. Biogen Orphan Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 97. Takeda Corporate Summary
Table 98. Takeda Orphan Drugs Product Offerings
Table 99. Takeda Orphan Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 100. Amgen Corporate Summary
Table 101. Amgen Orphan Drugs Product Offerings
Table 102. Amgen Orphan Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 103. Orphan Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 104. Global Orphan Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 105. Global Orphan Drugs Production by Region, 2017-2022 (K Units)
Table 106. Global Orphan Drugs Production by Region, 2023-2028 (K Units)
Table 107. Orphan Drugs Market Opportunities & Trends in Global Market
Table 108. Orphan Drugs Market Drivers in Global Market
Table 109. Orphan Drugs Market Restraints in Global Market
Table 110. Orphan Drugs Raw Materials
Table 111. Orphan Drugs Raw Materials Suppliers in Global Market
Table 112. Typical Orphan Drugs Downstream
Table 113. Orphan Drugs Downstream Clients in Global Market
Table 114. Orphan Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Orphan Drugs Segment by Type
Figure 2. Orphan Drugs Segment by Application
Figure 3. Global Orphan Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Orphan Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Orphan Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Orphan Drugs Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Orphan Drugs Revenue in 2021
Figure 9. By Type - Global Orphan Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Orphan Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Orphan Drugs Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Orphan Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Orphan Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Orphan Drugs Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Orphan Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Orphan Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Orphan Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Orphan Drugs Sales Market Share, 2017-2028
Figure 19. US Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Orphan Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Orphan Drugs Sales Market Share, 2017-2028
Figure 24. Germany Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Orphan Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Orphan Drugs Sales Market Share, 2017-2028
Figure 33. China Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Orphan Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Orphan Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Orphan Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Orphan Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Orphan Drugs Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Orphan Drugs by Region, 2021 VS 2028
Figure 50. Orphan Drugs Industry Value Chain
Figure 51. Marketing Channels
